Contact information
Country: | China |
---|---|
Tel: | 0531-88110457 |
Mobile: | 15562555968 |
E-mail: | info@pharmachemm.com |
QQ: | 982893012 |
Skype: | Chat Now! |
Address: | Zhengfeng Road |
Gold product
- CAS:1078-21-3
- Purity:99%
- CAS:3054-47-5
- Purity:0.99
- CAS:72432-10-1
- Purity:99%min
Company Profile
Jianfeng Chemical is a research-driven pharmaceutical company.We have more than 10 years experience in the pharmacy filed. Mainly manufactures pharmaceutical APIs,Pharmaceutical intermediate and Cosmetic raw material.Our main products are Apixaban Intermediate, Lurasidone Intermediate, Peramivir Intermediate,Tianeptine Sodium , Febuxastat , Imatinib Mesylate , Glutathione ect. The products meet USP, EP, JP and CP standards and are available not only in China but also in the US, Germany, Canada, Japan, etc. To meet market demands, Jianfeng set up one R&D center, two GMP workshops and three pharmaceutical & chemical factories.In the principle of "Quality Oriented", Jianfeng passed the certification of ISO9001:2008 Quality Management System. Our products are based on bulk, high volume, wholesale price, third party testing, certificate reporting, and bring high quality ingredients to many domestic and overseas enterprises. "Honesty, practicality, innovation, development" are our values. Jianfeng would like to cooperate with you with high quality products and competitive price.
Enterprise Basic Information

Enterprise Certification
![]() |
|
Type of Enterprise: | Manuefactory |
Legal Representative: | Changbao Guo |
Registered Capital: | 10000000 |
Founded Date: | 2011-07-26 |
Registered Address: | 902-A, Building 2, Jigaoda Data Industry Center, No. 879 Shunhua Road, High tech Industrial Developm |
Term of Validity: | 2011-07-26—2050-12-31 |
Business Scope: | Development, production and sales of chemical products (excluding hazardous chemicals and poisonous substances) and pharmaceutical intermediates; technological development, technology transfer and consulting services for pharmaceuticals and chemical products; import and export of goods and other items not prohibited by laws, regulations and decisions of the State Council, and not subject to operating licences. (Items subject to approval by law, can only carry out business activities after approval by the relevant departments) |
Staff number: | 50-100 People |
Number of R & D department: | 1-5 |
Annual turnover: | RMB Below RMB 1 million |
Main consumer market: | Pharmaceutical factory Fine chemical plant Research InstituteL trading company Medical materials factory |
Main marketing location: | India United States Vietnam Pakistan United Kingdom |
Main product or service: | Various pharmaceutical intermediates,API,Apixaban intermediate,Lurasidon intermediate,Peramivir intermediate,Montelukast Intermediate |
Manufacturer
Marketing : | Jinan Jianfeng Chemical Co., Ltd |
Address: | 902-A, Building 2, Jigaoda Data Industry Center, No. 879 Shunhua Road Street, Lixia District, Jinan City, Shandong Province, China |
Area: | 200m2 |
Pictures of scenes: | |
|
Marketing : | Jinan Jianfeng Chemical Co., Ltd |
Address: | Lixia District, Jinan City, Shandong Province, China |
Area: | 8000m2 |
Equipment: | HPLC, GC, Reaction kettle |
Pictures of scenes: | |
|
Brief description : | Jianfeng passed the certification of ISO9001:2008 Quality Management System. The products meet USP, EP, JP and CP standards and are available not only in China but also in the US, Germany, Canada, Japan, etc. To meet market demands, Jianfeng set up one R&D center, two GMP workshops and three pharmaceutical & chemical factories. |
Quality inspection equipment: | HPLC, GC, Reaction kettle |
|
|
Certificate of accreditation: | ISO |
|
Brief description : | 5000m2 50 reaction kettles |
Pictures of scenes: | |
Staff composition for example: | Our company is equipped with a large number of product research and development personnel and product quality inspection department, and can also conduct third-party testing and provide product qualification certificates |
Professional skills: | Production, Research and Development |
Pictures of scenes: | |
|